| |
 |
|
|
Bridgehead International
Board Appointment
January 2008
Richard Wallace
joins Bridgehead International Board
Richard J Wallace has joined the Bridgehead
Board as a Non-Executive Director, following 15 years at GlaxoSmithKline
(GSK), where he was most recently Senior Vice President of
Global Product Strategy, accountable for Global Health Outcomes,
Scientific Communications, Global Commercial Strategy and
Business & Commercial Analysis. He also served as a member
of its Research and Development Executive, Commercial Operations
Committee, Product Management Board and Scientific Advisory
Board. During his years at GSK and its heritage companies,
Richard held positions from Vice President Commercial (Canadian
Pharmaceuticals), Vice President U.S. Business Development,
Vice President Sales & Marketing (U.S. Oncology and HIV),
Vice President Clinical Development and Product Strategy,
and Vice President of Global Commercial Strategy.
His experience prior
to joining GSK included eight years with Bristol-Myers Squibb
and seven years at Johnson & Johnson in assignments from
Marketing, Sales, Manufacturing and General Management.
Richard received
BCom and BCom(Hons) degrees from Rhodes University, South
Africa and currently serves on the board of directors of Avigen
Inc, ImmunoGen Inc and Clinical Data Inc.
|
|
Bridgehead International CEO, Timothy
Fitzgerald commented: "We are delighted at Richard's
decision to join the team at a time when we are pushing ahead
with a major expansion of our activities in North America.
His senior level experience, particularly in the market access
and health outcomes fields will be of real value to Bridgehead
and its clients."
Over the past four years Bridgehead's
Market Access business has grown to be the single largest
practice area in the company.
- Payer research
- Therapy area scanning
- Pricing strategy for commercialisation
- Reimbursement negotiation strategy
- Product life cycle pricing strategy
- Pharmacoeconomic assessments
- Health technology assessment support
Top
|
About Bridgehead International
Bridgehead International
is a leading biopharmaceutical consultancy group, offering
a range of services designed to assist clients in achieving
extraordinary growth across the product and technology value
chain, through three practice areas:
- Market Access Solutions, including market
assessments and development of pricing and reimbursement
strategies.
- Technical and Commercial Evaluation,
covering due diligence, expert reports and decision support.
- Healthcare Education Services,
focused on specialist medical education for those working
in the pharmaceutical and biotechnology industry.
With over 50 consultants and associates
in Europe, North America and Asia, Bridgehead Consulting
provides a powerful combination of strategic, scientific,
medical, technical, commercial, economic, decision support,
modelling and intellectual property skills and experience.
|
